Alkeon Capital Management Portfolio holdings
AUM
$20.6B
This Quarter Return
+4.39%
1 Year Return
+8.97%
3 Year Return
+43.14%
5 Year Return
+49.88%
10 Year Return
+256.15%
AUM
$21.6B
AUM Growth
+$21.6B
(+14%)
Cap. Flow
+$1.71B
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
30.45%
Holding
157
New
14
Increased
50
Reduced
19
Closed
15
Top Buys
| 1 |
Salesforce
CRM
|
$327M |
| 2 |
Pinterest
PINS
|
$299M |
| 3 |
Apple
AAPL
|
$296M |
| 4 |
CoStar Group
CSGP
|
$236M |
| 5 |
Meta Platforms (Facebook)
META
|
$183M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$165M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$164M |
| 3 |
Boeing
BA
|
$91.8M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
$89.1M |
| 5 |
ServiceNow
NOW
|
$85.8M |
Sector Composition
| 1 | Technology | 45.35% |
| 2 | Consumer Discretionary | 18.31% |
| 3 | Communication Services | 9.51% |
| 4 | Financials | 8% |
| 5 | Healthcare | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Akero Therapeutics
AKRO
$3.61B
| $70.2M | 0.13% |
2,280,707
+1,282,333
| +128% | +$39.5M |
|
77
Restaurant Brands International
QSR
$20.5B
| $69.4M | 0.13% |
1,207,283
| – | – |
|
|
IGMS
78
DELISTED
IGM Biosciences
IGMS
| $68.6M | 0.13% |
928,800
+175,000
| +23% | +$12.9M |
|
79
Martin Marietta Materials
MLM
$36.7B
| $68.2M | 0.13% |
289,962
-80,111
| -22% | -$18.9M |
|
80
Electronic Arts
EA
$42.1B
| $65.5M | 0.12% |
501,899
| – | – |
|
81
Alnylam Pharmaceuticals
ALNY
$59.1B
| $64.2M | 0.12% |
440,976
-66,524
| -13% | -$9.69M |
|
82
NXP Semiconductors
NXPI
$57.2B
| $61.2M | 0.11% |
490,000
| – | – |
|
83
Micron Technology
MU
$132B
| $48.8M | 0.09% |
1,039,697
+509,697
| +96% | +$23.9M |
|
84
RTX Corp
RTX
$211B
| $47.1M | 0.09% |
818,196
-260,000
| -24% | -$15M |
|
85
Unity
U
$16.6B
| $43.6M | 0.08% |
+500,000
| New | +$43.6M |
|
|
TPTX
86
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $41.7M | 0.08% |
477,000
| – | – |
|
|
ALTR
87
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $36.7M | 0.07% |
875,000
| – | – |
|
88
Microchip Technology
MCHP
$33.6B
| $36.5M | 0.07% |
355,000
-45,000
| -11% | -$4.62M |
|
89
Parsons
PSN
$8.49B
| $35.2M | 0.07% |
1,050,093
+10,900
| +1% | +$366K |
|
90
Snowflake
SNOW
$76.6B
| $35.1M | 0.07% |
+140,000
| New | +$35.1M |
|
|
DCPH
91
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $34.4M | 0.06% |
670,975
| – | – |
|
92
Karyopharm Therapeutics
KPTI
$59.6M
| $31.6M | 0.06% |
2,164,900
+100,000
| +5% | +$1.46M |
|
|
KLRS
93
Kalaris Therapeutics, Inc. Common Stock
KLRS
$81.5M
| $30.2M | 0.06% |
+1,097,000
| New | +$30.2M |
|
94
Mersana Therapeutics
MRSN
$35.7M
| $28.9M | 0.05% |
+1,550,000
| New | +$28.9M |
|
95
Take-Two Interactive
TTWO
$44.2B
| $28.6M | 0.05% |
173,222
-172,800
| -50% | -$28.6M |
|
96
Zoom
ZM
$25B
| $28.2M | 0.05% |
60,000
| – | – |
|
97
Avidity Biosciences
RNA
$5.97B
| $24.6M | 0.05% |
875,000
+100,000
| +13% | +$2.81M |
|
98
American Well
AMWL
$109M
| $23.7M | 0.04% |
+800,000
| New | +$23.7M |
|
99
Datadog
DDOG
$45.9B
| $22M | 0.04% |
215,000
+40,000
| +23% | +$4.09M |
|
100
PMV Pharmaceuticals
PMVP
$81.1M
| $16.9M | 0.03% |
+475,000
| New | +$16.9M |
|